CalciMedica, Inc.
CALC
$4.69
$0.091.96%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.77M | 2.57M | 2.27M | 2.34M | 2.19M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.62M | 6.62M | 6.50M | 6.17M | 5.74M |
| Operating Income | -5.62M | -6.62M | -6.50M | -6.17M | -5.74M |
| Income Before Tax | -7.80M | -5.96M | -5.04M | -4.26M | -5.62M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.80M | -5.96M | -5.04M | -4.26M | -5.62M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.80M | -5.96M | -5.04M | -4.26M | -5.62M |
| EBIT | -5.62M | -6.62M | -6.50M | -6.17M | -5.74M |
| EBITDA | -5.61M | -6.61M | -6.48M | -6.16M | -5.72M |
| EPS Basic | -0.52 | -0.40 | -0.36 | -0.33 | -0.50 |
| Normalized Basic EPS | -0.32 | -0.25 | -0.22 | -0.21 | -0.32 |
| EPS Diluted | -0.52 | -0.40 | -0.36 | -0.33 | -0.50 |
| Normalized Diluted EPS | -0.32 | -0.25 | -0.22 | -0.21 | -0.32 |
| Average Basic Shares Outstanding | 15.08M | 15.00M | 14.12M | 12.96M | 11.14M |
| Average Diluted Shares Outstanding | 15.08M | 15.00M | 14.12M | 12.96M | 11.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |